Daily Stock List
Orgenesis, Inc. (ORGS)
Stock News Now, Streetwise Reports, Greenbackers, and SmallCapNetwork reported earlier on Orgenesis, Inc. (ORGS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Orgenesis, Inc. is a fully-integrated biopharmaceutical company based in Germantown, Maryland. It has a novel therapeutic technology for the treatment of diabetes. Moreover, it has a fully-owned subsidiary contract manufacturing and development company called MaSTherCell. This subsidiary’s dedication is to cell therapy for advanced medicinal products. A development stage enterprise, Orgenesis lists on the OTC Markets’ OTCQB.
Orgenesis has expertise and unique experience in cell therapy development and manufacturing. In addition, by way of its Israeli subsidiary, Orgenesis Ltd., Orgenesis is a pioneer in the development of technology designed to successfully reprogram human liver cells into glucose-responsive, fully functional, Insulin Producing Cells (IPCs).
The Company has a novel therapeutic approach in the treatment of diabetes through correcting malfunctioning organs with new functional tissues created from the patient’s own existing organs. Orgenesis employs a molecular and cellular approach directed at transforming liver cells into functional insulin-producing cells as a treatment for diabetes. The new therapeutic approach is called Autologous Insulin Producing (AIP) cell transplantation.
The Company states that there are more than 50 centers around the world that are highly qualified for Pancreatic Islet transplantation. Orgenesis’ intention is to work closely with these leading centers to enable Autologous Insulin Producing (AIP) cell transplantation as a therapeutic approach in the treatment of diabetes at those centers.
The foundation of Orgenesis’ technology is on Intellectual Property (IP) licensed from Israel’s recognized Sheba Medical Center. The basis of the portfolio is on the pioneering work and two decades of research by the acclaimed researcher, Prof. Sarah Ferber.
Orgenesis has demonstrated promising results in in-vitro and in-vivo studies using human liver tissues. The Company has designed an efficient and clear work-plan to start clinical testing soon, permitting it to launch Phase I clinical trials following Food and Drug Administration (FDA) guidelines followed by the launch of Phase II clinical trials within a year.
Last month, Orgenesis Ltd., the wholly-owned subsidiary of Orgenesis, announced that it and South Korean-based CureCell Co. Ltd. were awarded a collaborative grant from the Korea-Israel Industrial R&D Foundation (KORIL-RDF) to finance their present co-development program. The program will include pre-clinical and clinical activities related to commercialization of the Orgenesis Autologous Insulin Producing (AIP) Cells for the treatment of diabetes. Orgenesis Ltd. will own the rights to any IP developed from the collaboration that is related to Orgenesis Ltd.'s AIP cell therapy product, or derived from information licensed from Tel Hashomer Hospital in Israel, and/or Orgenesis Ltd.'s confidential information.
Vered Caplan, Orgenesis’ Chief Executive Officer, said, "A grant from KORIL-RDF will enable us to work closely with CureCell to fund advanced research and development initiatives to provide a therapy for insulin-dependent diabetic patients."
Orgenesis, Inc. (ORGS), closed Tuesday's trading session at $0.515, even for the day. The average volume for the last 60 days is 7,696 and the stock's 52-week low/high is $0.2352/$0.515.
Paragon Shipping, Inc. (PRGNF)
Today we are reporting on Paragon Shipping, Inc. (PRGNF), here at the QualityStocks Daily Newsletter.
Paragon Shipping, Inc. is a global shipping company specializing in the transportation of drybulk cargoes. Established in 2006, the Company, incorporated under the laws of the Republic of the Marshall Islands, has its executive offices in Athens, Greece. Its management team has in excess of 60 years of combined experience in shipping in all operational and financial facets of the business. OTCQB-listed, Paragon Shipping provides shipping transportation services around the world.
The Company engages in the ocean transportation of drybulk cargoes, including commodities, such as iron ore, coal, grain, and other materials. Following the delivery of the three Kamsarmax newbuildings in Q3 and Q4 of 2016, Paragon Shipping’s fleet carrying capacity will total around 245,400 deadweight tons (dwt).
The business strategy of the Company centers on building and maintaining lasting relationships with charterers and providing reliable seaborne transportation services at competitive rates. Paragon works to acquire and operate drybulk vessels and use them in a combination of "spot charter", and "period time charter" contracts.
Paragon Shipping’s fleet of dry bulk vessels consists of the aforementioned three Kamsarmax newbuildings. These are Hull No. 1142, Hull No. 1144, and Hull No. 1145. Each of these vessels is 81,800 dwt. The dry bulk shipping sector involves the global transportation of cargoes in bulk, including iron ore, coal, agricultural products, cement, phosphates, and more.
The Company entered into an agreement with Jiangsu Yangzijiang Shipbuilding Co., to extend the deliveries of its three Kamsarmax newbuilding drybulk carriers (Hull numbers YZJ1144, YZJ1145 and YZJ1142), to September 30, 2016, October 31, 2016 and November 30, 2016, correspondingly, subject to certain conditions.
Paragon Shipping, by way of Allseas, its vessel management company, has established relationships with foremost charterers and several brokerage houses internationally. Paragon chooses high-quality second hand vessels and employs a proactive preventative maintenance program, ashore and at sea. Furthermore, it competitively commissions reliable, cost efficient shipyards to perform repairs, reconditioning and systems upgrading work.
Paragon Shipping, Inc. (PRGNF), closed Tuesday's trading session at $0.40, even for the day, on 1,939 volume with 20 trades. The average volume for the last 60 days is 39,793 and the stock's 52-week low/high is $0.20/$45.60.
Matinas BioPharma Holdings, Inc. (MTNB)
Tiny Gems, SmallCapVoice, Stock News Now, and Stock News reported on Matinas BioPharma Holdings, Inc. (MTNB), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company headquartered in Bedminster, New Jersey. It focuses on identifying and developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections. The Company’s proprietary, disruptive technology uses lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable.
Matinas BioPharma’s focus is on the development and commercialization of lipid-based prescription therapeutics for the treatment of infectious diseases and cardiovascular and metabolic conditions. The Company’s emphasis is on creating highly differentiated, safe, and efficacious therapies utilizing its expertise in drug formulation and development to address important unmet medical needs.
More recent additions to its product pipeline, including MAT2203 and MAT2501, position Matinas to become a leader in the safe and effective delivery of anti-infective therapies employing its proprietary lipid-crystal nano-particle cochleate formulations. Matinas’ intention is to file an investigational new drug application (IND) for MAT2501.
The Company has its clinical development strategy for MAT2203 (its lead drug candidate), a novel lipid-crystal nano-particle orally delivered formulation of Amphotericin B for the treatment of invasive fungal infections, and MAT2501, an early-stage program to treat gram-negative bacterial infections using an orally available formulation of Amikacin, a broad spectrum aminoglycoside.
Matinas BioPharma also has its investigational drug MAT9001. This is a proprietary prescription-only omega-3 fatty acid-based composition, consisting of docosa-pentaenoic acid (DPA) and other omega-3 fatty acids, which is under development for therapeutic applications with severe hypertriglyceridemia (TG>500 mg/dL) as the lead indication. Matinas has purposely designed MAT9001 to provide a differentiated pharmacotherapy for the treatment of dyslipidemia.
Matinas BioPharma has received a Notice of Allowance of U.S. patent for encochleated siRNA, providing a pathway to the development of orally administered RNA based therapies. Matinas BioPharma’s investigational drug MAT2501 (encochleated amikacin) was granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of non-tuberculous mycobacteria (NTM) infections, its lead chronic indication.
Last month, Matinas BioPharma announced it received a Notice of Issuance from the U.S. Patent and Trademark Office (USPTO) for U.S. Patent Application Serial No. 14/609,235 entitled, “Cochleates Made with Soy Phosphatidylserine.” The patent was issued as U.S. Patent No. 9,370,572. It provides intellectual property (IP) protection through 2033.
Last week, Matinas BioPharma announced the presentation of efficacy results in animal models of cryptococcal meningitis resulting from treatment with the Company’s investigational drug, MAT2203 (orally-administered encochleated amphotericin B), under development for the treatment of serious fungal infections, at the AIDS-Associated Mycoses scientific meeting, which was held July 13-15 in Capetown, South Africa.
In a presentation at the meeting, scientists from the National Institute of Allergy and Infectious Diseases (NIAID) showed that they could effectively treat mice infected with cryptococcal meningitis in two experiments using an orally administered lipid-crystal nano-particle formulation of amphotericin B (MAT2203). The National Institute of Allergy and Infectious Diseases (NIAID) is part of the National Institutes of Health (NIH).
Matinas BioPharma Holdings, Inc. (MTNB), closed Tuesday's trading session at $0.61, down 11.59%, on 20,392 volume with 10 trades. The average volume for the last 60 days is 37,363 and the stock's 52-week low/high is $0.411/$1.15.
NAC Global Technologies, Inc. (NACG)
Information Solutions Group reported previously on NAC Global Technologies, Inc. (NACG), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
NAC Global Technologies, Inc. manufactures and supplies harmonic gearing technology. The Company’s platform harmonic gearing technology is used in the automation, robotics, and the defense industries. NAC engages in the application of its drives in emerging technologies. This includes advanced robotics and clean energy. A development and manufacturing enterprise, NAC Global Technologies is based in Jacksonville, Florida. The Company’s shares trade on the OTC Bulletin Board.
NAC has one operating subsidiary, NAC Drive Systems, Inc. NAC manufactures and warehouses products in Port Jervis, New York and in Beijing, People’s Republic of China through a strategic partnership agreement with CTKM Beijing Harmonic Drive, Ltd., the national HGT supplier to the China Space Agency.
Regarding the above-mentioned harmonics, they are important drives to manifold industries. These industries include robotics, semi-conductor, aerospace, and defense. Harmonic technology is also extensively used in motion control applications where precision, long-life, compactness, and reliability are essential features.
In addition to its harmonic gearing technology (HGT) product line, NAC Global Technologies engages in the commercialization of new non-hazardous, non-volatile, environmentally friendly fuel cells suitable for use in aircraft and portable power. The Company is building a core of enabling and foundational technology for Automation, Clean Tech Energy, and Defense. Its NAC Drive Systems subsidiary provides harmonic gearing and controls for automation, robotics, defense, printing, corrugated, communications, electronics, as well as medical applications.
NAC Global Technologies has strategic initiatives to develop and expand its application scope into developing clean energy and advanced force sensing robotic applications. The Company’s core HGT technology is ideally suited to a broad assortment of positioning applications. This includes developing applications in solar collector power generation. HGT technology’s zero backlash, high efficiency attributes make it ideal for precise positioning at a distance and low power consumption. Consequently, this increases the overall net power generated.
Regarding Sensory Feedback Robotics Prosthetics, NAC is looking to further expand into the health care market with specialized drives for medical/surgical robots and prosthetic limbs. The Company’s belief is that many of the characteristics offered by its core drive technology may offer benefit in these applications.
NAC Global Technologies, Inc. (NACG), closed Tuesday's trading session at $0.0383, even for the day. The average volume for the last 60 days is 26,200 and the stock's 52-week low/high is $0.015/$0.18.
bBooth, Inc. (BBTH)
Cannabis Financial Network News reported earlier on bBooth, Inc. (BBTH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
bBooth, Inc. is connecting Hollywood to hometowns through placing professional-quality recording studios in local malls. The Company manufactures and operates Internet connected, broadcast-quality portable recording studios in the United States. It operates and markets its studios under the ‘bBooth’ brand.
The Company formerly went by the name Cutaia Media Group, LLC. It changed its name to bBooth, Inc. in May 2014. Established in 2012, bBooth is based in West Hollywood, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.
In essence, bBooth is the junction between entertainment, social media and technology. The Company provides new opportunities for rising talent to engage with Hollywood auditions, events and ‘insider’ content. The Company’s booths accommodate different kinds of talent. This includes singers, actors, comedians, models, hosts, personalities, newscasters, bands, songwriters, and anyone wishing to express themselves and/or be discovered.
bBooth’s bNotifi technology is a push-to-screen, interactive audio/video messaging and communications application. It is for industry leading social engagement on mobile/desktop/web platforms. bNotifi push-to-screen technology brings a person (for example, a celebrity, music artist, brand spokesperson, etc.) or product to life directly on the screens of fans' computers, tablets and mobile devices worldwide.
Regarding the bBooth Recording Studios, the Company is deploying kiosk-sized, family-friendly, professional-quality, TV recording studios in local shopping centers across the nation. Performances in bBooth are seen and heard on huge exterior monitors.
bBooth enables people to see the talent of tomorrow performing at the malls today. In addition, performances are seen on the Company’s app and shared across social media platforms. In essence, bBooth is a life-size, ‘SmartPhone’ style, interactive recording kiosk.
Some features of bBooth Recording Studios kiosks include a life-size interactive touchscreen display; an integrated HD camera that records high-quality video and stills; pro-quality, uni-directional mic minimized background noise; optional choice of karaoke songs with on-screen lyrics, and also custom branding options.
Mr. Nick Cannon has recently joined bBooth as Global Brand Ambassador. He is a renowned producer, writer, director, actor, DJ, entrepreneur and acclaimed host of TV's "America's Got Talent."
bBooth, Inc. (BBTH), closed Tuesday's trading session at $0.10, down 16.67%, on 166,800 volume with 15 trades. The average volume for the last 60 days is 52,701 and the stock's 52-week low/high is $0.025/$3.00.
Singlepoint, Inc. (SING)
The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0085, even for the day, on 915,876 volume with 31 trades. The stock’s average daily volume over the past 60 days is 725,905, and its 52-week low/high is $0.0041/$0.018.
Singlepoint, Inc. is pleased to announce that Milost Advisors has identified acquisition targets for a leveraged buyout by SinglePoint, in addition to funding necessary to execute the acquisition(s) alongside its SEC registration for listing on the OTCQB. We expect to announce news on acquisitions and financing in the near future. The Company is nearing completion on the audit for SinglePoint's Form 10 with MaloneBailey, a PCAOB firm based in Houston, Texas. Research firm L. Alan Davis has issued a favorable detailed market analysis on SinglePoint that shareholders are encouraged to review.
Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.
SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.
SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.
As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer
Singlepoint, Inc. Company Blog
Singlepoint, Inc. News:
SinglePoint, Inc. Identifies Acquisition and Funding Targets; Updates on MaloneBailey Audit Toward Uplist
A New Audio Interview with Greg Lambrecht, CEO of SinglePoint Inc., is Now at SmallCapVoice.com
SinglePoint, Inc. Announces Senate Approval of Daily Fantasy Sports Bill; Predicts DraftFury to Become Top Player in Multi-Billion Dollar DFS Market
Cherubim Interests, Inc. (CHIT)
The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.03903, up 30.10%, on 63,000 volume with 5 trades. The stock’s average daily volume over the past 60 days is 4,045, and its 52-week low/high is $0.03/$300.00.
Cherubim Interests, Inc. was pleased to announce that it has executed a Letter of Intent with SVN|TJF Investments. The Company and SVN|TJF Investments will work in a joint venture within the Dallas/Fort Worth Metroplex that will develop, construct, and lease a number of yet to be determined single-family residences that will then be divested to a pre-determined purchaser for amounts based on cap rates conducive to their respective geographic areas.
Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.
The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.
Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.
Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer
Cherubim Interests, Inc. Company Blog
Cherubim Interests, Inc. News:
Cherubim Interests, Inc. Signs LOI to Construct Single-Family Residential Rental Properties
Cherubim Interests, Inc. Announces Letter to Shareholders
Cherubim Interests, Inc. Acquires Victura Roofing and Cherubim Builders Group Oklahoma
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $1.83, up 0.60%, on 5,325 volume with 3 trades. The stock’s average daily volume over the past 60 days is 7,806, and its 52-week low/high is $0.51/$1.976.
Agent-Owned Cloud Brokerage Powered By the Same Underlying Technology as Pokémon GO.
eXp World Holdings, Inc. highlighted Pokémon GO today, the new mobile augmented reality game, which has almost instantaneously become one of the most downloaded, most used and most talked about gaming apps in history. eXp Realty was the first real estate brokerage to adopt a 3D immersive environment to power what had previously been more traditional bricks and mortar offices. Through a massive research effort in early 2009, eXp Realty was looking for a way to collaborate with brokers and agents in multiple markets nationwide without having to invest in more traditional infrastructure.
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
Pokemon GO's Popularity Not Surprising to eXp Realty
eXp Realty Launches in New Jersey
eXp Realty Launches in Utah
Laguna Blends Inc. (LAGBF)
The QualityStocks Daily Newsletter would like to spotlight Laguna Blends Inc. (LAGBF). Today, Laguna Blends Inc. closed trading at $0.23, up 9.52%, on 11,700 volume with 2 trades. The stock’s average daily volume over the past 60 days is 16,363, and its 52-week low/high is $0.069/$0.235.
Laguna Blends Inc. (LAGBF) is a network marketing company focused on the generation of sales through independent affiliates. Leveraging innovative tools and technologies, the company's affiliates are able to build international businesses from their own homes while effectively capitalizing on the performance of some of the world's most rapidly expanding, in-demand markets. To date, Laguna's primary focus has been on the hyper growing hemp food and beverage marketplace. As part of these efforts, the company introduced Caffe, a hemp-infused instant coffee product, and is preparing to launch Pro369, a water soluble hemp protein powder.
As a network marketing company, Laguna is strategically positioned to grow very quickly following its entry into the rapidly expanding hemp market space. In early March 2016, the company gave prospective shareholders a preview of this potential when it launched sales of its protein coffee beverage through 135 independent affiliates throughout the United States and Canada. In less than a week, Laguna's affiliate base grew by more than 100 percent to include 278 independent marketers, demonstrating the high levels of demand for functional beverage products across North America, as well as the considerable interest in the viable business opportunity Laguna presents to its affiliates.
Through the commercialization of Caffe and Pro369, Laguna is establishing a foothold in two high-demand global markets. According to reports from the Coffee Association of Canada (CAC), coffee is consumed by a larger proportion of adults than any other beverage, excluding water. In recent years, the emergence of energy drinks has slowed the coffee industry's performance, but the single cup serving market, of which Caffe is a part, has maintained steady growth, rising above 32 percent market share as of January 2014, according to Mintel Research. With a product in this space - as well as the global hemp industry, which was valued at nearly $500 million in 2012 by the Hemp Industries Association - Laguna's initial offerings position it strongly for sustainable growth.
With growth through its marketing network already underway, Laguna has turned its attention toward further expansion of its product line. In March 2016, the company signed a letter of intent with Robert Lamberton Consulting regarding the development of a "Limitless functional beverage brain health and memory coffee" product. Under the terms of this LOI, all hard costs associated with the development of the product will be billed to Robert Lamberton Consulting. The two parties are expected to enter into a formal research and development agreement outlining the details of this arrangement in the second quarter of 2016.
Laguna is the first network marketing Company to use exciting virtual 3D technology to enable affiliates to train, recruit and drive sales by utilizing a simple interactive platform. Laguna believes this technology is a game changer in the Direct Selling / Network Marketing Industry. Disclaimer
Laguna Blends Inc. Company Blog
Laguna Blends Inc. News:
Laguna Recaps Key Milestones, Drivers to Corporate Growth Strategy
Laguna Announces that the Clinical Trial Data of CBD Cannaceuticals Facial Serum Resulted in a 100% Overall Improvement of the Skin Appearance Within Two Weeks
Laguna Signs Letter of Intent to Acquire Distribution Rights of Swiss Made Cannaceuticals CBD Skin Care Line and License of Brand Name in an Exclusive Licence Agreement that Includes Clinical Trials and Existing Inventory
Star Mountain Resources, Inc. (SMRS)
The QualityStocks Daily Newsletter would like to spotlight Star Mountain Resources, Inc. (SMRS). Today, Star Mountain Resources, Inc. closed trading at $0.37, up 5.71%, on 8,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 3,084, and its 52-week low/high is $0.30/$1.25.
Star Mountain Resources, Inc. (SMRS), a minerals exploration company, is focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts. The company's operations are currently focused on the initiation, production and expansion of acquired mineral resources in the Star Mountain Mining District, Beaver County, Utah and turning them into producing assets.
Comprised of 2,320 acres, the company's Star Mountain/Chopar Mine project consists of 116 lode-mining claims and four metalliferous mineral lease sections located in the Star Mountain range, Star Mining District, in Beaver County, Utah, approximately five miles west of Milford, Utah. Exploration activities to date include geological analysis, and a limited reverse circulation & core drilling program.
The Star Mountain Mining District, which is dotted with historic mines dating back to the late 1800s, has a long and storied history within the mining industry. The company believes that the application of modern exploration tools will reveal additional resources that were previously unattainable. Leveraging the region's mild climate and accessibility to nearby rail lines and roads, management will look to translate this potential into sustainable returns in the years to come.
Star Mountain Resources has adopted a discovery-based business model to grow its industry presence in the future. The company plans to thoroughly explore and initially develop its leasehold before seeking senior industry partners to assist in the capital-intensive development and operation phases. Building on this strategy, Star Mountain Resources will also continue to seek quality projects that can be evaluated on their own technical and financial merit. Disclaimer
Star Mountain Resources, Inc. Company Blog
Star Mountain Resources, Inc. News:
Star Mountain Resources Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust
Star Mountain Resources Receives Industry Guide 7 Mineral Reserves Report on Balmat Mine
Star Mountain Resources, Inc. Closes Acquisition of Balmat Zinc Mine in New York State
Today's Top 3
Wall Street Mover
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Agora Holdings, Inc. (AGHI) Audit Is Complete, Company Continuing to Progress Its Plans to Move Up the Board to QB Level
- Alternet Systems (ALYI) Data Analytics Solution Gains Momentum with New Clients and Partners
- Cherubim Interests, Inc. (CHIT) Signs LOI to Construct Single-Family Residential Rental Properties
- Dominovas Energy Corp. (DNRG) Announces Plan to Restructure and Consolidate Outstanding Debt
- eXp World Holdings, Inc. (EXPI) Pokemon GO's Popularity Not Surprising to eXp Realty
- FlexWeek, Inc. (FXWK) Stay in Vacation Homes around the World for Less than the Cost of Hotels
- Giggles N' Hugs, Inc. (GIGL) engages Kiddos, Inc. and Michelle Steinberg of dOMAIN Integrated to Launch New Marketing and PR Initiatives
- International Stem Cell Corp. (ISCO) Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation
- Laguna Blends Inc. (LAGBF) Recaps Key Milestones, Drivers to Corporate Growth Strategy
- Momentous Entertainment Group, Inc. (MMEG) Outlines Aggressive Growth Business Plan
- Monaker Group, Inc. (MKGI) Shareholder Update
- Moxian, Inc. (MOXC) Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data
- OurPet's Company (OPCO) Now Licensing Polymer Bonded Pet Bowl Patent
- Singlepoint, Inc. (SING) Identifies Acquisition and Funding Targets; Updates on MaloneBailey Audit Toward Uplist
- Star Mountain Resources Inc. (SMRS) Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust
- WRIT Media Group, Inc. (WRIT) Announces Development of Blockchain-Based Payment Systems